Life Sciences.

Creating solutions to the world's most-pressing health issues.

Life Sciences

Enara Bio raises $32.5 million Series B financing to advance pipeline of TCR-based immunotherapies

9th October 2024

Life Sciences

Oxford Brain Diagnostics and Memory Treatment Centers enter collaboration

8th October 2024

Life Sciences

Emergex Receives Patent Protection for First-in-Class Influenza A Vaccines with Potential to Provide Long-Term T Cell Immunity

2nd September 2024

Life Sciences

Oxford part of new international Pioneer Centre for medical data research

2nd September 2024

Life Sciences

‘Origami-inspired’ folding electrodes could reduce surgery needed to treat brain conditions

13th August 2024

Life Sciences

Recursion and Exscientia Enter Definitive Agreement to Create a Global Technology-Enabled Drug Discovery Leader with End-to-End Capabilities

13th August 2024

Life Sciences

Ellison Institute expands to new building on The Oxford Science Park to accommodate growth

8th August 2024

Life Sciences

Neutrons help explain the relationship between air pollution and neurological disease

6th August 2024

Life Sciences

New therapies developed by Oxford experts offer online support for anxiety and post-traumatic stress disorders 

31st July 2024

Life Sciences

Mace awarded contract to deliver The Daubeny Project at The Oxford Science Park

31st July 2024

Life Sciences

Apollo Therapeutics and the University of Oxford enter into drug discovery and development collaboration

22nd July 2024

Life Sciences

Mission Street and BGO sign leading biotech Nucleome Therapeutics at Inventa, central Oxford’s first commercial science scheme

18th July 2024

Life Sciences

Yellowstone Biosciences spinout launches to advance cutting-edge cancer therapies from University of Oxford research

18th July 2024

Life Sciences

Moa harvests global deal for new herbicide

16th July 2024

Life Sciences

Pain Cloud® Launch: A Collaboration between EptivA and Infopoly Ltd., creating an advanced solution to Pain Research

10th July 2024

Life Sciences

IOI drug development programme joins ENABLE-2

10th July 2024